Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
OpenAI CEO Sam Altman has broken his silence on the Chinese startup DeepSeek that sent shockwaves through Silicon Valley when it released its AI model R1. OpenAI CEO Sam Altman has broken his ...
OpenAI CEO Sam Altman downplayed the significance of a new artificial intelligence (AI) model released by Chinese startup DeepSeek on Thursday, saying it did a “couple of nice things” but has ...
The price of Worldcoin jumped Wednesday, leading the crypto market after OpenAI's $500 billion AI initiative was unveiled.
Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive information. Sam Altman hailed the Chinese firm's low-cost AI model ...